Articles
Supporting material for partners evaluating Sylva.
Clinical evidence
Why Sylva breaks from fifty years of diagnosis-led treatment protocols and builds its clinical content on a four-layer evidence framework instead.
Read article →
Support model
How Sylva's AI mentors were built, trained and clinically evidenced, and how their fidelity is continuously verified.
Read article →
Neurodiversity profile validity
A commissioner's guide to Appendix D, the COSMIN standard, and seven questions to put to any neurodiversity profiling supplier.
Read article →
SaMD regulatory status
Why Sylva is regulated as a medical device in Great Britain, and what that means for commissioning partners.
Read article →
Product benefits
The benefits of Sylva's needs-based profiling module, built entirely from published, validated questionnaires.
Read article →